Maged Shenouda

Chief Financial Officer

Chief Financial Officer at RELMADA THERAPEUTICS, INC., filing insider transactions between 2026-09-09 and 2026-09-10.

Total Purchases

$844K

2 transactions

Total Sales

—

0 transactions

Companies Traded

2 total filings

Active Since

2026-09-09

Last: 2026-09-10

Companies

RELMADA THERAPEUTICS, INC.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-09-10	RLMD	Purchase	79.8K	$4.25	$339K	1.00M	SEC ↗
2026-09-09	RLMD	Purchase	120.2K	$4.20	$505K	920.2K	SEC ↗